MedTrace Logo

COVID-19 Antibody Levels After Vaccines

NCT04944134 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2022-08-01

No results posted yet for this study

Summary

This study will measure the levels of nasal mucosal Immunoglobulin A (IgA) and blood serum IgA up to one year after COVID vaccination, as well as examining what factors might affect antibody levels in the nose. This will be done through nasal epithelial lining fluid collection and standard venipuncture.

Conditions

  • Vaccine Preventable Disease

Interventions

BIOLOGICAL

COVID-19 Vaccination

Receipt of full COVID-19 vaccination

Sponsors & Collaborators

  • Environmental Protection Agency (EPA)

    collaborator FED

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Ilona Jaspers, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04944134 on ClinicalTrials.gov